专利名称:Tetrahydrocyclopenta[c]acridine derivatives
as kinase inhibitors and biological
发明人:Philippe Olivier Belmont,Laurent
Meijer,Philip Cohen,Amaury Patin,JohannBosson,Peter Gregory Goekjian
申请号:US12735463申请日:20090119公开号:US08999955B2公开日:20150407
摘要:The invention relates to kinase inhibitors of the formula (I) in which —Rto R═H;ether or polyether, amino; NO; NH-carbamate; NH—CO—R, with R such as defined above;Nand derivatives thereof of the 1,2,3-triazole type; —R=—OH; halogen; —OR with R suchas defined above; OH-carbamate; OH-carbonate; NH, NH-carbamate; NH—CO—R, with Rsuch as defined above; Nand derivatives thereof of the 1,2,3-triazole type; N(R,R); —R′═Hor a C1-C12 alkyl, —R═H; R; (R or R′)—Si, with R such as defined above; optionally
substituted aryl, heteroaryl; halogen (iodine); alkynyl; —Rand R═H, C-Calkyl; —Rand R═H,R (or R′) such as defined above. These compounds can be used as kinase inhibitors inparticular for treating cancer.
申请人:Philippe Olivier Belmont,Laurent Meijer,Philip Cohen,Amaury Patin,JohannBosson,Peter Gregory Goekjian
地址:Lyons FR,Roscoff FR,Dundee GB,Villeurbanne FR,Etrembières FR,Lyons FR
国籍:FR,FR,GB,FR,FR,FR
代理机构:Nixon & Vanderhye P.C.
更多信息请下载全文后查看
因篇幅问题不能全部显示,请点此查看更多更全内容